Figure 5From: Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysemaChronology of clinical events in an MZ-AAT patient with severe persistent asthma. AAT: Alpha1-antitrypsin. FEV1: Forced Expiratory Volume in 1 second.Back to article page